# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-029112
Filing Date
2023-08-11
Accepted
2023-08-11 17:05:45
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20230630.htm iXBRL | 10-Q | 830954
2 | EX-10.1 | amendmentno3totheamendedan.htm | EX-10.1 | 6286
3 | EX-31.1 | a2023q2-exhibit311.htm | EX-31.1 | 12548
4 | EX-31.2 | a2023q2-exhibit312.htm | EX-31.2 | 12542
5 | EX-32.1 | a2023q2-exhibit321.htm | EX-32.1 | 6875
| Complete submission text file | 0001628280-23-029112.txt |  | 4148051

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20230630.xsd | EX-101.SCH | 34287
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20230630_cal.xml | EX-101.CAL | 51027
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20230630_def.xml | EX-101.DEF | 132401
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20230630_lab.xml | EX-101.LAB | 392336
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20230630_pre.xml | EX-101.PRE | 257690
51 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20230630_htm.xml | XML | 412813

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 231165099
SIC: 2834 Pharmaceutical Preparations